Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system

Eur J Heart Fail. 2022 Feb;24(2):257-273. doi: 10.1002/ejhf.2400. Epub 2022 Feb 16.

Abstract

This is the first part of a scientific statement from the Heart Failure Association (HFA) of the European Society of Cardiology focused upon the pathophysiology of Takotsubo syndrome and is complimentary to the previous HFA position statement on Takotsubo syndrome which focused upon clinical management. In part 1 we provide an overview of the pathophysiology of Takotsubo syndrome and fundamental questions to consider. We then review and discuss the central role of catecholamines and the sympathetic nervous system in the pathophysiology, and the direct effects of high surges in catecholamines upon myocardial biology including β-adrenergic receptor signalling, G-protein coupled receptor kinases, cardiomyocyte calcium physiology, myofilament physiology, cardiomyocyte gene expression, myocardial electrophysiology and arrhythmogenicity, myocardial inflammation, metabolism and energetics. The integrated effects upon ventricular haemodynamics are discussed and integrated into the pathophysiological model.

Keywords: Beta-adrenergic signalling; Catecholamine; Electrophysiology; G-protein coupled receptor kinase; Inflammation; Metabolism; Pathophysiology; Takotsubo syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiology*
  • Catecholamines
  • Heart Failure*
  • Humans
  • Sympathetic Nervous System
  • Takotsubo Cardiomyopathy*

Substances

  • Catecholamines